Jurox TMPS Antibacterial Solution for Injection

국가: 오스트레일리아

언어: 영어

출처: APVMA (Australian Pesticides and Veterinary Medicines Authority)

유효 성분:

TRIMETHOPRIM; SULFADOXINE

제공처:

JUROX PTY LIMITED

약제 형태:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

구성:

TRIMETHOPRIM PYRIMIDINE Active 40.0 mg/ml; SULFADOXINE SULFANYL Active 200.0 mg/ml

패키지 단위:

100 mL

수업:

VM - Veterinary Medicine

치료 영역:

ANTIBIOTIC & RELATED

제품 요약:

Poison schedule: 4; Withholding period: MEAT: (CATTLE, SHEEP, PIGS): DO NOT USE less than 14 days before slaughter for h uman consumption. (HORSES): DO NOT USE l ess than 28 days before slaughter for hu man consumption. MILK: Milk collected from cows and ewes within 36 hours (3 m ilkings) following a single treatment or 72 hours (6 milkings) following the las t of multiple treatments, MUST NOT BE US ED or processed for human consumption, o r fed to bobby calves. Any variation by the prescribing veterinarian to the a pproved dose, frequency, duration, route , disease or target species may result i n the need to extend the approved withho lding period. An ESI has not been estab lished for this product. Note - observi ng the meat withholding period may not b e sufficient to mitigate potential risks to export trade. Trade advice should be sought from Jurox Pty Limited on 1800 0 23 312 before using the product.; Host/pest details: CAT: [ORGANISMS SENSITIVE TO SULFADOXINE, ORGANISMS SENSITIVE TO TRIMETHOPRIM]; CATTLE: [ORGANISMS SENSITIVE TO SULFADOXINE, ORGANISMS SENSITIVE TO TRIMETHOPRIM]; DOG: [ORGANISMS SENSITIVE TO SULFADOXINE, ORGANISMS SENSITIVE TO TRIMETHOPRIM]; HORSE: [ORGANISMS SENSITIVE TO SULFADOXINE, ORGANISMS SENSITIVE TO TRIMETHOPRIM]; PIGS: [ORGANISMS SENSITIVE TO SULFADOXINE, ORGANISMS SENSITIVE TO TRIMETHOPRIM]; SHEEP: [ORGANISMS SENSITIVE TO SULFADOXINE, ORGANISMS SENSITIVE TO TRIMETHOPRIM]

승인 상태:

Registered

승인 날짜:

2023-07-01

환자 정보 전단

JUROX TMPS ANTIBACTERIAL SOLUTION FOR INJECTION
89895/126306
Product Name:
APVMA Approval No:
Label Name:
JUROX TMPS ANTIBACTERIAL SOLUTION FOR INJECTION
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
200 mg/mL SULFADOXINE
40 mg/mL TRIMETHOPRIM
Claims:
Jurox TMPS Antibacterial Solution for Injection contains 40 mg/mL
trimethoprim, a
synthetic antibacterial developed in the Wellcome Research
Laboratories, and 200 mg/mL
sulfadoxine, a long acting sulfonamide.
Jurox TMPS Antibacterial Solution for Injection is effective against
most Gram-positive and
Gram-negative bacteria. The two components of Jurox TMPS Antibacterial
Solution for
Injection produce a sequential double blockade of bacterial metabolism
giving a level of
activity many times greater than that obtained from either drug alone.
For the treatment of infections caused by organisms sensitive to
trimethoprim and
sulfadoxine in cattle, sheep, pigs, horses, cats and dogs.
Jurox TMPS Antibacterial Solution for Injection is indicated for the
systemic treatment of:
Respiratory infections of bacterial origin including pneumonia,
bronchitis and secondary
bacterial infections following virus pneumonia.
Urogenital tract infections including cystitis, vaginitis, urethritis,
nephritis and metritis.
Alimentary tract infections including Escherichia coli infections and
salmonellosis.
Other infections, such as foul-in-the-foot, severe mastitis, bacterial
agalactia of sows, post-
operative and post-parturient uses, wound infections and septicaemias.
Jurox TMPS Antibacterial Solution for Injection is active in vitro
against Gram-positive
and Gram-negative organisms including Actinomyces spp., Bacillus
anthracis, Bordetella
spp., Brucella spp., Clostridium spp., Corynebacterium spp., E. coli,
Haemophilus spp.,
Klebsiella spp., Shigella spp., Staphylococci, Streptococci,
Pasteurella spp., Salmonella
spp., Fusiformis spp., and Campylobacter spp.
Note: Erysipelothrix, Leptospira and Pseudomonas organis